Exobiosphere
We are revolutionizing drug discovery with our proprietary and space based Orbital High-Throughput Testing platform. By testing in space pharmaceutical and biotech companies to identify and optimize therapeutic compounds with unmatched precision and speed.
We are strategically positioned at the intersection of biotechnology and space exploration. Our partnerships with leading research institutions, launch partners and space agencies enable us to deliver groundbreaking solutions for the most complex therapeutic challenges.
Meet the Team
-
Kyle Acierno, Co-Founder & Chief Executive Officer
Kyle Acierno is a prominent leader in the space and biotech sectors, known for his transformative impact on businesses and innovation. With a Master's degree in Space Science, Kyle has led the opening of three global offices, recruiting and managing teams of over 100 professionals. He has driven over $100M in sales, successfully navigated four venture capital funding rounds totaling $200M, and guided a company through its IPO on the Tokyo Stock Exchange in 2023.
With a global perspective gained from traveling to 110 countries and fluency in Chinese, Kyle combines international insight with strategic leadership to deliver groundbreaking results.
-
Dr. Bruno Santos, Co-Founder & Director of R&D
Bruno Santos holds a PhD in Molecular Neuroscience and has over a decade of experience in translational research, with a strong focus on advancing scientific applications from the lab to real-world impact. His expertise spans stem cell and 3D organoid technologies, where he has led innovative projects to create complex tissue models for research and development. Bruno has also developed and deployed high-throughput automation systems that enhance experimental efficiency and data collection.
Outside of his scientific endeavors, Bruno is an accomplished photographer, capturing moments that showcase his creative vision and attention to detail.
-
DR. OLIVIA BORGUE, CO-FOUNDER & DIRECTOR OF ENGINEERING
An accomplished expert in space systems engineering, Olivia Borgue holds a PhD in Space Systems Engineering and brings over 8 years of hands-on experience in the field. She has contributed to the development of advanced payloads for LEO and lunar applications, highlighting her expertise in innovative space technologies. Olivia has also played a pivotal role in designing biotech payloads for the ISS, pushing the boundaries of research in microgravity environments.
Beyond her technical achievements, Olivia is also a licensed helicopter pilot, demonstrating her versatility and passion for exploration.
-
Nach Dave, RPh, Global Head of Business Development
Nach is an experienced pharmaceutical and medical device industry professional of 23 years. He received his B.S. in Pharmacy from the University of Sciences- Philadelphia and a Masters in Regulatory Science from Long Island University-Brooklyn. He has worked in strategic positions in drug development at large pharma and CROs. In addition to industry appointments, he has also served as an adjunct professor at Long Island University and a visiting professor at University of Southern California Keck School of Medicine. Nach has also generated over 50MM in revenues while working in past positions as a Business Developer in the Pharmaceutical and CRO industries. He has been a key strategist for several start-ups and has a demonstrated track record for growing small to mid-sized healthcare companies. Currently, Nach is based in New Jersey.